Skip to main content
Earnings Labs
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN)

NASDAQ·Healthcare·Biotechnology

$13.11

+2.74%

Mkt Cap $760.73M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (10 analysts)

$20.50

Range $20.00$21.00

Implied Upside

+56.4%

Consensus $20.50 vs current $13.11